Skip to content

Drug interactions

Idelalisib + Nimodipine

Severity: Major

Idelalisib and Nimodipine: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Idelalisib is a strong CYP3A inhibitor, and nimodipine is highly dependent on CYP3A4 for clearance. Nimodipine concentrations can rise substantially, risking marked hypotension and bradycardia.

What this interaction means in plain words

Idelalisib and Nimodipine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Idelalisib belongs to Oncology; Nimodipine belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Idelalisib inhibits CYP3A4, reducing nimodipine first-pass and systemic metabolism.

What to do

Avoid the combination. If unavoidable, monitor blood pressure and heart rate closely and reduce the nimodipine dose.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Idelalisib and Nimodipine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Idelalisib with Nimodipine?

MediHelp rates the interaction as major. Idelalisib and Nimodipine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Idelalisib is a strong CYP3A inhibitor, and nimodipine is highly dependent on CYP3A4 for clearance. Nimodipine concentrations can rise substantially, risking marked hypotension and bradycardia.

How serious is the interaction between Idelalisib and Nimodipine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination. If unavoidable, monitor blood pressure and heart rate closely and reduce the nimodipine dose.

What other medicines interact with Nimodipine?

MediHelp also lists interactions of Nimodipine with, for example, Apalutamide, Carbamazepine, Ceritinib. The full list is on the Nimodipine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in